RP
CCEL icon

Rowlandmiller & Partners’s Cryo-Cell International CCEL Stock Holding History

Rowlandmiller & Partners’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,433
Closed -$107K – 187
2024
Q4 		$107K Buy
+14,433
New +$109K 0.02% 178
2024
Q3 		– Sell
-14,433
Closed -$110K – 185
2024
Q2 		$110K Hold
14,433
– – 0.02% 169
2024
Q1 		$108K Buy
+14,433
New +$81.5K 0.02% 178
2022
Q1 		– Sell
-11,000
Closed -$128K – 188
2021
Q4 		$128K Buy
+11,000
New +$137K 0.03% 168

Other funds holding CCEL

HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.08B AUM 7.99% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rowlandmiller & Partners's CCEL Position: Q1 2025 in Review

Rowlandmiller & Partners sold out of Cryo-Cell International (CCEL) in Q1 2025, closing a stake of 14,433 shares — an estimated $107K sold.

Rowlandmiller & Partners first reported a position in CCEL in Q4 2021 and held it in 4 quarters. The position peaked at $128K in Q4 2021. 21 funds tracked by Wall St. Rank hold CCEL as of Q1 2025.

  • Rowlandmiller & Partners reported no remaining Cryo-Cell International position as of Q1 2025 after selling out during the quarter.
  • Rowlandmiller & Partners sold 14,433 Cryo-Cell International shares in Q1 2025, an estimated $107K.
  • Rowlandmiller & Partners first reported a position in Cryo-Cell International in Q4 2021 and held it in 4 quarters.
  • Rowlandmiller & Partners's Cryo-Cell International position peaked at $128K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2025.

Based on Rowlandmiller & Partners's 13F filing for Q1 2025, filed 15 Apr 2025.